Technical and clinical performance of the thermo-test device "Q-Sense" to assess small fibre function: A head-to-head comparison with the "Thermal Sensory Analyzer" TSA in diabetic patients and healthy volunteers.


Journal

European journal of pain (London, England)
ISSN: 1532-2149
Titre abrégé: Eur J Pain
Pays: England
ID NLM: 9801774

Informations de publication

Date de publication:
11 2019
Historique:
received: 14 03 2019
revised: 21 07 2019
accepted: 22 07 2019
pubmed: 31 7 2019
medline: 16 7 2020
entrez: 31 7 2019
Statut: ppublish

Résumé

Thermo-test devices are rarely used outside specialized pain centres because of high acquisition costs. Recently, a new, portable device ("Q-Sense") was introduced, which is less expensive but has reduced cooling capacity (20°C). We assessed the reliability/validity of the "Q-Sense" by comparing it with the Thermal Sensory Analyzer (TSA). Using a phantom-skin model, the physical characteristics of both devices were compared. The clinical performance was assessed in a multicentre study by performing Quantitative Sensory Testing (QST) in 121 healthy volunteers and 83 diabetic patients (Eudra-Med-No. CIV-12-05-006501). Both device types showed ~40% slower temperature ramps for heating/cooling than nominal data. Cold/warm detection thresholds (CDT, WDT) and heat pain thresholds (HPT) of healthy subjects did not differ between device types. Cold pain thresholds (CPT) were biased for Q-Sense by a floor effect (p < .001). According to intraclass correlation coefficients (ICC), agreement between TSA and Q-Sense was good/excellent for CDT (ICC = 0.894) and WDT (ICC = 0.898), moderate for HPT (ICC = 0.525) and poor for CPT (ICC = 0.305). In diabetic patients, the sensitivity of Q-Sense to detect cold hypoesthesia was reduced in males >60 years. Moderate correlations between thermal detection thresholds and morphological data from skin biopsies (n = 51) were similar for both devices. Physical characteristics of both thermo-test devices are similarly limited by the poor temperature conduction of the skin. The Q-Sense is useful for thermal detection thresholds but of limited use for pain thresholds. For full clinical use, the lower cut-off temperature should be set to ≤18°C. High purchase costs prevent a widespread use of thermo-test devices for diagnosing small fibre neuropathy. The air-cooled "Q-Sense" could be a lower cost alternative, but its technical/clinical performance needs to be assessed because of its restricted cut-off for cooling (20°C). This study provides critical information on the physical characteristics and the clinical validity/reliability of the Q-Sense compared to the "Thermal Sensory Analyzer" (TSA). We recommend lowering the cut-off value of the Q-Sense to ≤18°C for its full clinical use.

Sections du résumé

BACKGROUND
Thermo-test devices are rarely used outside specialized pain centres because of high acquisition costs. Recently, a new, portable device ("Q-Sense") was introduced, which is less expensive but has reduced cooling capacity (20°C). We assessed the reliability/validity of the "Q-Sense" by comparing it with the Thermal Sensory Analyzer (TSA).
METHODS
Using a phantom-skin model, the physical characteristics of both devices were compared. The clinical performance was assessed in a multicentre study by performing Quantitative Sensory Testing (QST) in 121 healthy volunteers and 83 diabetic patients (Eudra-Med-No. CIV-12-05-006501).
RESULTS
Both device types showed ~40% slower temperature ramps for heating/cooling than nominal data. Cold/warm detection thresholds (CDT, WDT) and heat pain thresholds (HPT) of healthy subjects did not differ between device types. Cold pain thresholds (CPT) were biased for Q-Sense by a floor effect (p < .001). According to intraclass correlation coefficients (ICC), agreement between TSA and Q-Sense was good/excellent for CDT (ICC = 0.894) and WDT (ICC = 0.898), moderate for HPT (ICC = 0.525) and poor for CPT (ICC = 0.305). In diabetic patients, the sensitivity of Q-Sense to detect cold hypoesthesia was reduced in males >60 years. Moderate correlations between thermal detection thresholds and morphological data from skin biopsies (n = 51) were similar for both devices.
CONCLUSIONS
Physical characteristics of both thermo-test devices are similarly limited by the poor temperature conduction of the skin. The Q-Sense is useful for thermal detection thresholds but of limited use for pain thresholds. For full clinical use, the lower cut-off temperature should be set to ≤18°C.
SIGNIFICANCE
High purchase costs prevent a widespread use of thermo-test devices for diagnosing small fibre neuropathy. The air-cooled "Q-Sense" could be a lower cost alternative, but its technical/clinical performance needs to be assessed because of its restricted cut-off for cooling (20°C). This study provides critical information on the physical characteristics and the clinical validity/reliability of the Q-Sense compared to the "Thermal Sensory Analyzer" (TSA). We recommend lowering the cut-off value of the Q-Sense to ≤18°C for its full clinical use.

Identifiants

pubmed: 31359547
doi: 10.1002/ejp.1461
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1863-1878

Informations de copyright

© 2019 European Pain Federation - EFIC®.

Références

Abraham, A., Barnett, C., Katzberg, H. D., Lovblom, L. E., Perkins, B. A., & Bril, V. (2018). Toronto clinical neuropathy score is valid for a wide spectrum of polyneuropathies. European Journal of Neurology, 25(3), 484-490. https://doi.org/10.1111/ene.13533
Backonja, M. M., Attal, N., Baron, R., Bouhassira, D., Drangholt, M., Dyck, P. J., … Ziegler, D. (2013). Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain, 154(9), 1807-1819. https://doi.org/10.1016/j.pain.2013.05.047
Bland, J. M., & Altman, D. G. (1999). Measuring agreement in method comparison studies. Statistical Methods in Medical Research, 8(2), 135-160. https://doi.org/10.1177/096228029900800204
Bril, V., & Perkins, B. A. (2002). Validation of the toronto clinical scoring system for diabetic polyneuropathy. Diabetes Care, 25(11), 2048-2052. https://doi.org/10.2337/diacare.25.11.2048
Cicchetti, D. V. (1994). Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychological Assessment, 6(4), 284-290. https://doi.org/10.1037/1040-3590.6.4.284
Cruccu, G., Sommer, C., Anand, P., Attal, N., Baron, R., Garcia-Larrea, L., … Treede, R.-D. (2010). EFNS guidelines on neuropathic pain assessment: Revised 2009. European Journal of Neurology, 17(8), 1010-1018. ENE2969 [pii].https://doi.org/10.1111/j.1468-1331.2010.02969.x
Devigili, G., Tugnoli, V., Penza, P., Camozzi, F., Lombardi, R., Melli, G., … Lauria, G. (2008). The diagnostic criteria for small fibre neuropathy: From symptoms to neuropathology. Brain, 131(Pt 7), 1912-1925. https://doi.org/10.1093/brain/awn093
Dyck, P. J., Karnes, J., O'Brien, P. C., & Swanson, C. J. (1986). Neuropathy Symptom Profile in health, motor neuron disease, diabetic neuropathy, and amyloidosis. Neurology, 36(10), 1300-1308. https://doi.org/10.1212/WNL.36.10.1300
EFNS. (2010). European federation of neurological societies/peripheral nerve society guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European federation of neurological societies and the peripheral nerve society. Journal of the Peripheral Nervous System, 15(2), 79-92. https://doi.org/10.1111/j.1529-8027.2010.00269.x
Freynhagen, R., Baron, R., Gockel, U., & Tolle, T. R. (2006). painDETECT: A new screening questionnaire to identify neuropathic components in patients with back pain. Current Medical Research and Opinion, 22(10), 1911-1920. https://doi.org/10.1185/030079906x132488
Geber, C., Klein, T., Azad, S., Birklein, F., Gierthmühlen, J., Huge, V., … Treede, R.-D. (2011). Test-retest and interobserver reliability of quantitative sensory testing according to the protocol of the German research network on neuropathic pain (DFNS): A multi-centre study. Pain, 152(3), 548-556. https://doi.org/10.1016/j.pain.2010.11.013
Jia, Z. R., Wang, T. T., & Wang, H. X. (2014). Significance of quantitative sensory testing in the diagnosis of diabetic peripheral neuropathy. Journal of Clinical Neurophysiology, 31(5), 437-440. https://doi.org/10.1097/wnp.0000000000000086
Kopf, S., Groener, J. B., Kender, Z., Fleming, T., Bischoff, S., Jende, J., … Nawroth, P. P. (2018). Deep phenotyping neuropathy: An underestimated complication in patients with pre-diabetes and type 2 diabetes associated with albuminuria. Diabetes Res Clin Pract, 146, 191-201. https://doi.org/10.1016/j.diabres.2018.10.020.
Lauria, G., Hsieh, S. T., Johansson, O., Kennedy, W. R., Leger, J. M., Mellgren, S. I., … Valls-Sole, J. (2010). European federation of neurological societies/peripheral nerve society guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European federation of neurological societies and the peripheral nerve society. European Journal of Neurology, 17(7), 903-912, e944-909. https://doi.org/10.1111/j.1468-1331.2010.03023.x
Magerl, W., Krumova, E. K., Baron, R., Tolle, T., Treede, R. D., & Maier, C. (2010). Reference data for quantitative sensory testing (QST): Refined stratification for age and a novel method for statistical comparison of group data. Pain, 151(3), 598-605. S0304-3959(10)00448-3 [pii]. https://doi.org/10.1016/j.pain.2010.07.026
Maier, C., Baron, R., Tölle, T. R., Binder, A., Birbaumer, N., Birklein, F., … Treede, D.-R. (2010). Quantitative sensory testing in the German research network on neuropathic pain (DFNS): Somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain, 150(3), 439-450. S0304-3959(10)00272-1 [pii]. https://doi.org/10.1016/j.pain.2010.05.002
Mantyh, W. G., Dyck, P. J., Dyck, P. J., Engelstad, J. K., Litchy, W. J., Sandroni, P., & Davis, M. D. (2016). Epidermal nerve fiber quantification in patients with erythromelalgia. JAMA Dermatology, 153(2), 162. https://doi.org/10.1001/jamadermatol.2016.4404
Meijer, J. W., Smit, A. J., Sonderen, E. V., Groothoff, J. W., Eismal, W. H., & Links, T. P. (2002). Symptom scoring systems to diagnose distal polyneuropathy in diabetes: The diabetic neuropathy symptom score. Diabetic Medicine, 19(11), 962-965. https://doi.org/10.1046/j.1464-5491.2002.00819.x
Nauck, M., Petermann, A., Müller-Wieland, D., Kerner, W., Müller, U. A., Landgraf, R., … Heinemann, L. (2017). Definition, Klassifikation und Diagnostik des Diabetes mellitus. Diabetologie, 12(Suppl 2), S94-S100. https://doi.org/10.1055/s-0043-115953
Pfau, D. B., Krumova, E. K., Treede, R.-D., Baron, R., Toelle, T., Birklein, F., … Maier, C. (2014). Quantitative sensory testing in the German research network on neuropathic pain (DFNS): Reference data for the trunk and application in patients with chronic postherpetic neuralgia. Pain, 155(5), 1002-10105. https://doi.org/10.1016/j.pain.2014.02.004
Quattrini, C., Tavakoli, M., Jeziorska, M., Kallinikos, P., Tesfaye, S., Finnigan, J., … Malik, R. A. (2007). Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes, 56(8), 2148-2154. https://doi.org/10.2337/db07-0285
Raputova, J., Srotova, I., Vlckova, E., Sommer, C., Üçeyler, N., Birklein, F., … Bednarik, J. (2017). Sensory phenotype and risk factors for painful diabetic neuropathy: A cross-sectional observational study. Pain, 158(12), 2340-2353. https://doi.org/10.1097/j.pain.0000000000001034
Rolke, R., Magerl, W., Campbell, K. A., Schalber, C., Caspari, S., Birklein, F., & Treede, R. D. (2006). Quantitative sensory testing: A comprehensive protocol for clinical trials. European Journal of Pain, 10(1), 77-88. S1090-3801(05)00027-3 [pii].https://doi.org/10.1016/j.ejpain.2005.02.003
Spiegel, J., Hansen, C., & Treede, R. D. (2000). Clinical evaluation criteria for the assessment of impaired pain sensitivity by thulium laser evoked potentials. Clinical Neurophysiology, 111(4), 725-735. https://doi.org/10.1016/S1388-2457(99)00297-7
Terkelsen, A. J., Karlsson, P., Lauria, G., Freeman, R., Finnerup, N. B., & Jensen, T. S. (2017). The diagnostic challenge of small fibre neuropathy: Clinical presentations, evaluations, and causes. The Lancet Neurology, 16(11), 934-944. https://doi.org/10.1016/s1474-4422(17)30329-0
Themistocleous, A. C., Ramirez, J. D., Shillo, P. R., Lees, J. G., Selvarajah, D., Orengo, C., … Bennett, D. L. (2016). The Pain in Neuropathy Study (PiNS): a cross-sectional observational study determining the somatosensory phenotype of painful and painless diabetic neuropathy. Pain, 157(5), 1132-1145. https://doi.org/10.1097/j.pain.0000000000000491.
Tillman, D. B., Treede, R. D., Meyer, R. A., & Campbell, J. N. (1995). Response of C fibre nociceptors in the anaesthetized monkey to heat stimuli: Estimates of receptor depth and threshold. Journal of Physiology, 485(Pt 3), 753-765. https://doi.org/10.1113/jphysiol.1995.sp020766
Üçeyler, N., Vollert, J., Broll, B., Riediger, N., Langjahr, M., Saffer, N., … Sommer, C. (2018). Sensory profiles and skin innervation of patients with painful and painless neuropathies. Pain, 159(9), 1867-1876. https://doi.org/10.1097/j.pain.0000000000001287
Vlckova-Moravcova, E., Bednarik, J., Dusek, L., Toyka, K. V., & Sommer, C. (2008). Diagnostic validity of epidermal nerve fiber densities in painful sensory neuropathies. Muscle and Nerve, 37(1), 50-60. https://doi.org/10.1002/mus.20889
Vollert, J., Maier, C., Attal, N., Bennett, D. L. H., Bouhassira, D., Enax-Krumova, E. K., … Baron, R. (2017). Stratifying patients with peripheral neuropathic pain based on sensory profiles: Algorithm and sample size recommendations. Pain, 158(8), 1446-1455. https://doi.org/10.1097/j.pain.0000000000000935
Walk, D., Wendelschafer-Crabb, G., Davey, C., & Kennedy, W. R. (2007). Concordance between epidermal nerve fiber density and sensory examination in patients with symptoms of idiopathic small fiber neuropathy. Journal of the Neurological Sciences, 255(1-2), 23-26. https://doi.org/10.1016/j.jns.2007.01.052
Werner, M. U., Bischoff, J. M., & Kehlet, H. (2013). Good from far. Far from good. Pain, 154(1), 175-176. https://doi.org/10.1016/j.pain.2012.10.011
Wilcox, G. L., & Giesler, G. J., Jr (1984). An instrument using a multiple layer Peltier device to change skin temperature rapidly. Brain Research Bulletin, 12(1), 143-146. https://doi.org/10.1016/0361-9230(84)90227-2
Yarnitsky, D., Sprecher, E., Zaslansky, R., & Hemli, J. A. (1995). Heat pain thresholds: Normative data and repeatability. Pain, 60(3), 329-332. https://doi.org/10.1016/0304-3959(94)00132-X

Auteurs

Doreen B Pfau (DB)

Department of Neurophysiology, Medical Faculty Mannheim, Center of Biomedicine and Medical Technology, University of Heidelberg, Mannheim, Germany.

Wolfgang Greffrath (W)

Department of Neurophysiology, Medical Faculty Mannheim, Center of Biomedicine and Medical Technology, University of Heidelberg, Mannheim, Germany.

Andreas Schilder (A)

Department of Neurophysiology, Medical Faculty Mannheim, Center of Biomedicine and Medical Technology, University of Heidelberg, Mannheim, Germany.

Walter Magerl (W)

Department of Neurophysiology, Medical Faculty Mannheim, Center of Biomedicine and Medical Technology, University of Heidelberg, Mannheim, Germany.

Carolin Ohler (C)

Department of Neurophysiology, Medical Faculty Mannheim, Center of Biomedicine and Medical Technology, University of Heidelberg, Mannheim, Germany.

Andrea Westermann (A)

Center for Pain Medicine, BG University Hospital Bergmannsheil, Ruhr University Bochum, Bochum, Germany.

Christoph Maier (C)

Center for Pain Medicine, BG University Hospital Bergmannsheil, Ruhr University Bochum, Bochum, Germany.

Kathrin Doppler (K)

Department of Neurology, University Hospital Würzburg, Würzburg, Germany.

Claudia Sommer (C)

Department of Neurology, University Hospital Würzburg, Würzburg, Germany.

Michael Orth (M)

Department of Neurology, Ulm University, Ulm, Germany.

Hans-Peter Hammes (HP)

Department of Endocrinology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

Jochen Kurz (J)

MRC Systems GmbH, Heidelberg, Germany.

Marcus Götz (M)

MRC Systems GmbH, Heidelberg, Germany.

Rolf-Detlef Treede (RD)

Department of Neurophysiology, Medical Faculty Mannheim, Center of Biomedicine and Medical Technology, University of Heidelberg, Mannheim, Germany.

Sigrid Schuh-Hofer (S)

Department of Neurophysiology, Medical Faculty Mannheim, Center of Biomedicine and Medical Technology, University of Heidelberg, Mannheim, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH